Bioidentical hormone replacement therapy is not a risk-free treatment. Hormones are powerful signaling molecules that affect virtually every system in your body, and introducing them therapeutically — even in physiological doses — comes with a side effect profile that every patient deserves to understand clearly before starting. The fact that bioidentical hormones are molecularly identical to those your body produces does not mean they are without consequences. What it does mean is that when they are prescribed appropriately, dosed correctly, and monitored consistently, those consequences are manageable and the risk-benefit ratio is favorable for most patients. The side effects of BHRT fall into two broad categories: adjustment effects that occur as your body adapts to new or changed hormone levels, and true adverse effects that signal a problem with dosing, formulation, delivery method, or patient selection. Understanding which category a symptom falls into — and what to do about it — is one of the most important things a qualified provider helps you navigate. Side effects that are dismissed as “normal” without investigation, and side effects that are treated with alarm when they are actually minor and dose-dependent, are both failures of clinical management. This article covers the side effects associated with each major hormone used in BHRT, distinguishes adjustment symptoms from warning signs, explains the most common causes of side effects and how they are managed, and clarifies which patient populations require extra caution.
What You Need to Know
Most side effects of BHRT are dose-dependent, meaning they occur because a dose is too high, too low, or poorly matched to the individual patient’s physiology. A side effect that appears in the first few weeks of therapy is often a signal to adjust — not to stop. A side effect that appears months into stable therapy requires investigation. And certain side effects are absolute signals to seek medical attention immediately, regardless of timing. The most important principle: side effects are most common when therapy is initiated without comprehensive baseline testing, when dosing is based on a standardized protocol rather than an individual’s labs and symptoms, or when monitoring after initiation is inadequate. Proper evaluation before starting, appropriate dose selection, and consistent follow-up are not optional add-ons — they are what makes the difference between a side effect and a well-managed treatment.
Side Effects of Estrogen (Estradiol)
Estrogen is the primary hormone addressed in menopausal therapy for women. The bioidentical form, 17β-estradiol, is available in FDA-approved transdermal, oral, and vaginal formulations. Side effects vary by dose and delivery route.
- Breast tenderness or fullness: One of the most common early side effects. Usually a sign that the dose is higher than what the individual needs, or that estrogen is not balanced by adequate progesterone. Typically resolves with dose adjustment. Does not indicate breast pathology on its own, but should be reported to your provider.
- Bloating and fluid retention: Estrogen promotes sodium and water retention at higher doses. This often presents as bloating, puffiness, or a feeling of heaviness in the lower body. Transdermal delivery, which bypasses the liver and produces more stable blood levels, tends to cause less fluid retention than oral estradiol.
- Headaches or migraines: Hormonal fluctuations — including fluctuations caused by estrogen therapy — can trigger headaches in susceptible individuals. Oral estradiol produces more variable blood levels and is more likely to trigger migraines than transdermal delivery, which provides steadier absorption.
- Nausea: More common with oral estrogen, which passes through the liver on first pass. Transdermal delivery bypasses this and significantly reduces nausea. Taking oral estrogen with food helps.
- Mood changes or irritability: Counterintuitively, too much estrogen — or estrogen that is insufficiently balanced by progesterone — can cause mood instability, anxiety, or irritability. This is sometimes called “estrogen dominance” and resolves with dose rebalancing.
- Spotting or irregular bleeding: Women who have not had a hysterectomy and are taking systemic estrogen without adequate progesterone may experience uterine stimulation and breakthrough bleeding. This is why progesterone is required alongside estrogen for women with an intact uterus. Any unexpected or heavy bleeding should be evaluated promptly.
- Venous thromboembolism (blood clots): Oral estrogen increases the risk of blood clots more than transdermal estradiol, which does not appear to increase clot risk at standard doses. This is one of the most clinically significant reasons to prefer transdermal delivery in women with any history of clotting risk, obesity, or prolonged immobility. The absolute risk with transdermal estradiol is low in healthy women without clotting disorders.
Important note on estrogen and breast cancer: The relationship between estrogen therapy and breast cancer is nuanced and depends heavily on whether a progestogen is used alongside it, and which progestogen. Estrogen alone (in women who have had a hysterectomy) has not been shown to increase breast cancer risk in most studies and may modestly reduce it. The breast cancer risk signal that emerged from the original Women’s Health Initiative study was associated primarily with the synthetic progestin medroxyprogesterone acetate (MPA), not with estradiol or bioidentical progesterone. More on this in the progesterone section below.
Side Effects of Micronized Progesterone
Micronized progesterone is the bioidentical form of progesterone used in BHRT. It has a distinctly different side effect profile from synthetic progestins, which is one of the primary clinical reasons bioidentical progesterone is preferred when estrogen must be opposed.
- Drowsiness or sedation: The most common side effect of oral micronized progesterone. Progesterone has a mild sedative effect through its metabolite allopregnanolone, which acts on GABA receptors in the brain. For most patients, this is actually a benefit — progesterone taken at bedtime improves sleep quality. For those who experience excessive daytime drowsiness, switching to a vaginal route of administration eliminates the sedative effect.
- Dizziness: Related to the same neurological mechanism as sedation. Usually mild and resolves when progesterone is taken at bedtime rather than during the day.
- Breast tenderness: Can occur with progesterone, though it is more commonly associated with estrogen excess or estrogen-progesterone imbalance. Usually resolves with dose adjustment.
- Bloating or mood changes (less common than with synthetic progestins): Micronized progesterone has a much lower incidence of the bloating, depression, and mood disturbances commonly associated with synthetic progestins. This difference is well-documented in comparative studies and is one of the most clinically meaningful distinctions between bioidentical and synthetic hormone therapy.
- Allergic reaction (rare): Prometrium, the FDA-approved oral micronized progesterone capsule, is formulated in peanut oil. Patients with peanut allergies cannot use it. Compounded micronized progesterone without peanut oil is available for these patients.
On the breast cancer question: micronized progesterone does not carry the same breast cancer risk signal as synthetic progestins. Multiple large cohort studies, including the E3N study involving over 80,000 French women, found that combined estradiol and micronized progesterone was not associated with increased breast cancer risk, while estradiol combined with synthetic progestins was. This distinction is now reflected in the prescribing guidance of major professional societies.
Side Effects of Testosterone
Testosterone is used in men to address andropause and clinically confirmed hypogonadism, and in women at much lower doses to support libido, energy, body composition, and bone density. Side effects differ substantially by sex and dose.
In Men:
- Elevated hematocrit (erythrocytosis): Testosterone stimulates red blood cell production. When hematocrit rises above normal range (generally above 52–54%), blood viscosity increases and clotting risk rises. This is one of the most important safety labs to monitor in men on testosterone. Management includes dose reduction, switching delivery method (injectable testosterone carries higher hematocrit risk than transdermal), or therapeutic phlebotomy in severe cases.
- Testicular atrophy and reduced sperm production: Exogenous testosterone suppresses the pituitary signals (LH and FSH) that stimulate the testes. This leads to reduced testicular size and significantly impaired sperm production. Men who wish to preserve fertility should discuss this with their provider before starting testosterone, as fertility-preserving alternatives (such as clomiphene or hCG) may be appropriate.
- Acne or oily skin: Testosterone increases sebaceous gland activity. Acne is more common at higher doses. Usually mild and dose-dependent.
- Mood changes or irritability: Paradoxically, both too much and too little testosterone can contribute to mood instability. Supraphysiologic doses (above the normal range) are more likely to cause irritability, aggression, or emotional dysregulation. Optimal dosing within the normal physiological range generally improves mood.
- Estradiol elevation: Testosterone converts to estradiol through a process called aromatization. In men with higher body fat or a genetic predisposition to aromatize more readily, testosterone therapy can result in elevated estradiol, which causes symptoms including gynecomastia (breast tissue enlargement), water retention, and mood changes. An aromatase inhibitor may be needed in some cases.
- Prostate effects: Testosterone does not cause prostate cancer, but it can stimulate existing prostate tissue. Men on testosterone therapy require monitoring of PSA (prostate-specific antigen) and prostate symptoms. Testosterone is contraindicated in men with active or recently treated prostate cancer.
- Sleep apnea: Testosterone can worsen obstructive sleep apnea in men who are already predisposed. Screening for sleep apnea before initiating testosterone therapy is standard of care.
In Women:
- Acne: The most common side effect of testosterone in women, usually at doses that are too high. Low-dose testosterone for women uses a fraction of the male dose, and acne at physiological female doses is typically mild and resolves with dose reduction.
- Increased facial or body hair (hirsutism): Hair growth in androgen-sensitive areas can occur, particularly with doses above physiological female range. This is dose-dependent and a clear signal to reduce the dose.
- Voice deepening: A rare but potentially irreversible side effect at supraphysiologic doses. This is why conservative dosing in women is essential and why careful monitoring matters.
- Clitoral enlargement: Can occur at higher doses. Dose-dependent and reversible if caught early.
- Mood changes: Appropriate doses of testosterone in women generally improve mood, energy, and motivation. Doses that are too high can cause irritability or anxiety.
Side Effects of DHEA
DHEA is a precursor hormone that the body converts into estrogens and androgens. It is available over the counter as a supplement, though prescription-grade DHEA through a compounding pharmacy provides more precise dosing. Vaginal DHEA (Intrarosa) is FDA-approved for dyspareunia.
- Acne and oily skin: The most common side effect, related to DHEA’s conversion to androgens. Dose-dependent.
- Hair thinning: In women with a genetic predisposition to androgenic alopecia, DHEA supplementation can accelerate hair thinning due to androgen conversion.
- Mood effects: DHEA has complex neurological effects. Some patients report improved mood and motivation; others, particularly at higher doses, report anxiety or irritability.
- Hormonal imbalances: Because DHEA converts to multiple hormones, its effects are less predictable than prescribing specific hormones directly. Monitoring DHEA-S, testosterone, and estradiol levels after initiating DHEA is important for identifying downstream hormonal changes.
How Delivery Method Affects Side Effects
The route by which hormones are delivered significantly influences their side effect profile. This is one of the most clinically important factors in individualized hormone prescribing.
- Oral estrogen vs. transdermal estradiol: Oral estrogen passes through the liver on first pass, which increases clotting protein production, raises triglycerides, and produces more variable blood levels. Transdermal estradiol bypasses the liver, does not increase clot risk at standard doses, and provides steadier absorption. For most women — particularly those with any cardiovascular or clotting risk — transdermal delivery is the preferred route.
- Injectable testosterone vs. transdermal testosterone: Testosterone injections produce significant peaks and troughs in blood levels, which can cause mood fluctuations, energy variability, and higher hematocrit risk compared to transdermal delivery. Weekly or twice-weekly injections minimize this variability compared to biweekly injections.
- Hormone pellets: Pellets release hormones continuously over 3–6 months and cannot be adjusted or removed once inserted. The inability to modify the dose is a clinically significant limitation. If a patient develops side effects from a pellet dose that is too high — particularly elevated hematocrit, acne, or androgenic symptoms in women — those side effects must be managed medically until the pellet is exhausted rather than by simply reducing the dose. This is the primary clinical reason pellets are not considered first-line therapy.
- Vaginal estrogen: Low-dose vaginal estrogen is considered very safe even for women who cannot use systemic hormone therapy, including most breast cancer survivors, because systemic absorption is minimal at approved doses. Local side effects are limited to mild initial irritation that typically resolves.
Side Effects That Require Immediate Medical Attention
Most BHRT side effects are manageable through dose adjustment and do not require emergency intervention. However, the following symptoms require prompt or urgent medical evaluation regardless of timing:
- Chest pain, shortness of breath, or rapid heart rate
- Sudden severe headache unlike your usual headaches
- One-sided weakness, numbness, facial drooping, or slurred speech (signs of stroke)
- Calf pain, swelling, or warmth (possible deep vein thrombosis)
- Unexplained vaginal bleeding in a postmenopausal woman
- Breast lump or breast skin changes
- Sudden vision changes
- Signs of severely elevated hematocrit: headache, facial flushing, fatigue, dizziness
If you experience any of these symptoms while on hormone therapy, seek medical care immediately and inform the treating clinician that you are on hormone therapy.
Safety and Who Should Use BHRT with Caution
BHRT is not appropriate for everyone. Patients with the following histories require careful individual risk-benefit analysis before initiating any hormone therapy:
- Personal history of estrogen-sensitive cancers (breast, uterine, ovarian)
- Personal or strong family history of blood clots, stroke, or pulmonary embolism
- Active or uncontrolled cardiovascular disease
- Active liver disease
- Unexplained vaginal bleeding
- Uncontrolled hypertension
- Prostate cancer or significantly elevated PSA (men)
- Obstructive sleep apnea (particularly relevant for men considering testosterone)
The presence of any of these conditions does not automatically exclude hormone therapy — but it does require a more thorough individual evaluation, close monitoring, and in some cases a modified approach such as local vaginal estrogen only rather than systemic therapy.
Next Steps
At our practice, every BHRT protocol begins with a comprehensive evaluation of your health history, risk factors, and labs — because side effects are most often a consequence of inadequate evaluation and monitoring, not of the therapy itself. We use the lowest effective dose, prefer FDA-approved delivery methods where clinically appropriate, and monitor consistently to catch and address side effects early. We offer both in-person care in Central Ohio and telemedicine consultations nationwide.
Sources
Frequently Asked Questions
What are the most common side effects of BHRT?
The most common side effects of BHRT are dose-dependent and include breast tenderness, bloating, fluid retention, headaches, and mood changes with estrogen; drowsiness and mild dizziness with oral micronized progesterone; and acne, oily skin, and elevated hematocrit with testosterone. Most of these are signals that the dose needs adjustment rather than signs that therapy should be stopped. Side effects are significantly more common when therapy is initiated without comprehensive baseline testing, when dosing follows a standardized protocol rather than individual lab data, or when monitoring after initiation is inadequate.
Are the side effects of BHRT different from conventional HRT?
Yes, meaningfully so — particularly regarding the progestogen component. Synthetic progestins like medroxyprogesterone acetate (MPA), which were used in the original Women’s Health Initiative study, are associated with higher rates of bloating, depression, mood disturbances, and breast cancer risk than micronized progesterone. Multiple large observational studies have found that combined estradiol and micronized progesterone carries a more favorable side effect and risk profile than combined estrogen and synthetic progestin. The estrogen component of BHRT (17β-estradiol) has a similar side effect profile to conjugated equine estrogens, but transdermal estradiol carries significantly lower blood clot risk than oral estrogens of any type.
Can BHRT cause weight gain?
Properly dosed BHRT should not cause weight gain and often improves body composition over time by restoring the metabolic and hormonal environment that supports lean muscle and fat metabolism. What is sometimes mistaken for weight gain from BHRT is fluid retention — typically a sign that estrogen is too high or not adequately balanced by progesterone. True fat gain from BHRT is rare at physiological doses. In men, testosterone therapy at appropriate doses typically reduces visceral fat and improves lean muscle mass. In women, restoring estrogen and testosterone to optimal levels supports metabolic health and body composition rather than opposing it.
Does BHRT cause breast cancer?
This is one of the most important and most frequently misunderstood questions in hormone therapy. The short answer is: it depends on which hormones, which form, and which delivery method. Estrogen alone (in women without a uterus) does not appear to increase breast cancer risk in most studies and may modestly reduce it with long-term use. The breast cancer risk signal associated with combined hormone therapy in the original WHI study was driven primarily by the synthetic progestin MPA, not by estradiol. Multiple large studies have found that estradiol combined with micronized progesterone does not increase breast cancer risk and may be associated with a lower risk than estradiol combined with synthetic progestins. This distinction is clinically important and is now reflected in updated prescribing guidance from major menopause societies.
What side effects are specific to testosterone therapy in women?
The most common side effects of testosterone therapy in women are acne and increased facial or body hair, both of which are dose-dependent and resolve with dose reduction. These occur most often when doses are above the physiological range for women — which is significantly lower than the male dose. At appropriate low doses, testosterone therapy in women is generally well-tolerated. Rarely, at higher doses, voice deepening and clitoral enlargement can occur; these effects may be partially irreversible if not caught early. This is why conservative dosing and regular monitoring are essential for testosterone use in women.
Why do some people feel worse when they start BHRT?
Feeling worse in the first few weeks of BHRT is not uncommon and usually has one of several explanations. Your body may be adjusting to new hormone levels after a prolonged period of deficiency — this transition period can produce temporary symptoms including headaches, mood changes, or fatigue. The dose may not yet be optimized for your individual physiology. If progesterone is not adequate relative to estrogen, symptoms of estrogen excess (bloating, breast tenderness, irritability) can emerge. Or an underlying issue — thyroid dysfunction, adrenal dysregulation, nutrient deficiencies — may not have been addressed alongside the hormone protocol. Feeling worse at initiation is a signal to communicate with your provider, not to stop therapy without guidance.
What is estrogen dominance and is it a real side effect of BHRT?
Estrogen dominance refers to a state where estrogen’s effects are not adequately balanced by progesterone, either because estrogen is too high, progesterone is too low, or both. Symptoms include breast tenderness, bloating, fluid retention, mood instability, headaches, and irregular bleeding. It can occur in the context of BHRT when estrogen is prescribed without adequate progesterone, when progesterone dosing is insufficient, or when estrogen doses are higher than needed. It is a real clinical phenomenon and a common reason for side effects during hormone therapy. It resolves with rebalancing the estrogen-to-progesterone ratio — typically by adjusting the progesterone dose, reducing estrogen, or both.
Does testosterone therapy cause prostate cancer?
The evidence does not support a causal relationship between testosterone therapy and the development of prostate cancer. The “saturation model” of prostate androgen sensitivity suggests that once androgen receptors in prostate tissue are saturated — which occurs at relatively low testosterone levels — additional testosterone does not further stimulate prostate growth. However, testosterone therapy can stimulate pre-existing prostate cancer and is contraindicated in men with active or recently treated prostate cancer. Men on testosterone therapy require baseline PSA testing and regular PSA monitoring during treatment. A rising PSA on testosterone therapy warrants urological evaluation.
How long do side effects from BHRT last?
Most adjustment side effects — breast tenderness, mild bloating, initial mood changes, drowsiness from progesterone — resolve within 4–8 weeks as your body adapts to the new hormonal environment. Side effects that persist beyond this window are more likely signals that dosing needs adjustment. Side effects that are clearly dose-dependent (acne, elevated hematocrit, androgenic symptoms in women) persist for as long as the dose remains too high and resolve promptly with dose reduction. Side effects from hormone pellets are the exception — because pellets cannot be adjusted once inserted, dose-dependent side effects must be managed medically until the pellet is exhausted over 3–6 months.
What happens if my BHRT dose needs to be adjusted?
Dose adjustments are a normal and expected part of the process, particularly in the first three to six months of therapy. After your initial repeat labs (typically at eight to twelve weeks), your provider will review your hormone levels and symptom response and adjust your protocol accordingly. This might mean a dose increase if levels haven’t reached the target range, a dose decrease if levels are higher than optimal, a change in delivery method, or the addition of a supporting therapy. The goal is to find the lowest effective dose that relieves your symptoms and supports your health objectives.
Can I stop BHRT if I experience side effects?
Most side effects do not require abrupt discontinuation of therapy and are better addressed by dose adjustment or delivery method change than by stopping entirely. Abrupt discontinuation of hormone therapy can cause rebound symptoms — particularly a return of hot flashes, sleep disruption, and mood changes — that can be more disruptive than the side effect being managed. That said, certain side effects do warrant immediate discontinuation and medical evaluation: chest pain, signs of blood clot, stroke symptoms, unexpected vaginal bleeding, or a new breast lump. If you experience any of these, seek care immediately. For most other side effects, contact your provider to discuss adjustment options before making changes to your protocol.
Are side effects more common with compounded BHRT or FDA-approved products?
The side effect profile of a hormone is primarily determined by the hormone itself, the dose, and the delivery method — not by whether it was compounded or commercially manufactured. However, quality control differences are a real concern with compounded preparations. Inconsistent potency from compounding pharmacies that lack rigorous quality standards can result in doses that are higher or lower than prescribed, which increases the risk of dose-dependent side effects or inadequate symptom relief. FDA-approved products are manufactured under standardized conditions with consistent potency. This is one of the reasons FDA-approved bioidentical formulations are generally preferred when they meet the patient’s clinical needs, and why pharmacy quality matters when compounding is used.
Do you offer telehealth appointments?
Yes. We offer telehealth consultations for patients who prefer virtual visits or live outside our local area. Lab kits can be mailed directly to you, and consultations, lab reviews, protocol design, and ongoing monitoring can all be managed via video appointments. We serve clients nationwide.
This content is for educational purposes and does not substitute personalized medical advice.
